XML 119 R16.htm IDEA: XBRL DOCUMENT v2.4.0.6
DERIVATIVES
12 Months Ended
Dec. 31, 2012
DERIVATIVES
7. DERIVATIVES

The tables below represent the fair values of the Company’s derivative instruments reported within “other assets” and “other liabilities” and the fair value of the Company’s derivative liabilities relating to its obligation pertaining to Lazard Fund Interests and other similar deferred compensation arrangements reported within “accrued compensation and benefits” (see Note 14 of Notes to Consolidated Financial Statements) on the accompanying consolidated statements of financial condition as of December 31, 2012 and 2011:

 

    December 31,  
    2012          2011       

Derivative Assets:

   

Forward foreign currency exchange rate contracts

  $ 893      $ 4,245   

Equity and fixed income swaps and other

    40        2,886   
 

 

 

   

 

 

 
  $ 933      $ 7,131   
 

 

 

   

 

 

 

Derivative Liabilities:

   

Forward foreign currency exchange rate contracts

  $ 322      $ 445   

Interest rate swaps

    235        277   

Equity and fixed income swaps

    4,342        91   

Lazard Fund Interests and other similar deferred compensation arrangements

    97,593        29,900   
 

 

 

   

 

 

 
  $ 102,492      $ 30,713   
 

 

 

   

 

 

 

Net gains (losses) with respect to derivative instruments (predominantly reflected in “revenue-other”) and the Company’s derivative liabilities relating to its obligations pertaining to Lazard Fund Interests and other similar deferred compensation arrangements (included in “compensation and benefits” expense) as reflected on the accompanying consolidated statements of operations for the years ended December 31, 2012, 2011 and 2010, were as follows:

 

     Year Ended December 31,  
     2012     2011     2010  

Forward foreign currency exchange rate contracts

   $ (1,844   $ 2,422      $ 2,291   

Lazard Fund Interests and other similar deferred compensation arrangements

     (7,557     3,024          

Equity and fixed income swaps and other

     (18,327     4,276        (6,709
  

 

 

   

 

 

   

 

 

 
   $ (27,728   $ 9,722      $ (4,418
  

 

 

   

 

 

   

 

 

 

Derivatives designated as hedging instruments related to interest rate swaps that hedged “available-for-sale” securities and had been accounted for as fair value hedges. For the year ended December 31, 2010, the Company recognized pre-tax losses pertaining to interest rate swaps of $2,844. These losses were substantially offset by gains recognized on the hedged risk portion of such “available-for-sale” securities.